RSS
exclusivity agreement
Exclusivity agreement signed for retinal stem cell technology
UK developer of cell-based therapeutics, ReNeuron Group, has signed an exclusivity agreement with a US-based specialty pharma company in connection with the potential out-licensing of its hRPC retinal stem cell technology and therapeutic programmes. Read more
